Search research articles
Contact Us
Filters
Showing results (321-330 of 371) with videos related to
Page
of 38
Sort By:
The American Journal of Physiology
|
June 1, 1996
Rapid redistribution and inhibition of renal sodium transporters during acute pressure natriuresis
Y Zhang, A K Mircheff, C B Hensley, et al.
JIMD Reports
|
January 9, 2015
Cognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments
Virginia G Wadley, Leslie A McClure, David G Warnock, et al.
Plos One
|
June 24, 2011
A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy
Andreas D Kistler, Justyna Siwy, Frank Breunig, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 1, 1997
Acute renal failure in the 21st century: recommendations for management and outcomes assessment
T D DuBose, D G Warnock, R L Mehta, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 4, 2014
Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study
C Barrett Bowling, John N Booth, Orlando M Gutiérrez, et al.
Molecular Genetics and Metabolism
|
August 12, 2016
Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry
Robert J Hopkin, Gustavo Cabrera, Joel Charrow, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 10, 2010
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study
David G Warnock, Paul Muntner, Peter A McCullough, et al.
Kidney International
|
April 23, 2002
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran
Beckie Michael, Daniel W Coyne, Steven Fishbane, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 7, 2014
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study
Rikki M Tanner, David A Calhoun, Emmy K Bell, et al.
Molecular Genetics and Metabolism
|
January 10, 2012
Anti-α-galactosidase A antibody response to agalsidase beta treatment: data from the Fabry Registry
William R Wilcox, Gabor E Linthorst, Dominique P Germain, et al.
Page
of 38
Search research articles
Search
Showing results (321-330 of 371) with videos related to
Sort By:
Page
of 38
The American Journal of Physiology
|
June 1, 1996
Rapid redistribution and inhibition of renal sodium transporters during acute pressure natriuresis
Y Zhang, A K Mircheff, C B Hensley, et al.
JIMD Reports
|
January 9, 2015
Cognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments
Virginia G Wadley, Leslie A McClure, David G Warnock, et al.
Plos One
|
June 24, 2011
A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy
Andreas D Kistler, Justyna Siwy, Frank Breunig, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 1, 1997
Acute renal failure in the 21st century: recommendations for management and outcomes assessment
T D DuBose, D G Warnock, R L Mehta, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 4, 2014
Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study
C Barrett Bowling, John N Booth, Orlando M Gutiérrez, et al.
Molecular Genetics and Metabolism
|
August 12, 2016
Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry
Robert J Hopkin, Gustavo Cabrera, Joel Charrow, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 10, 2010
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study
David G Warnock, Paul Muntner, Peter A McCullough, et al.
Kidney International
|
April 23, 2002
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran
Beckie Michael, Daniel W Coyne, Steven Fishbane, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 7, 2014
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study
Rikki M Tanner, David A Calhoun, Emmy K Bell, et al.
Molecular Genetics and Metabolism
|
January 10, 2012
Anti-α-galactosidase A antibody response to agalsidase beta treatment: data from the Fabry Registry
William R Wilcox, Gabor E Linthorst, Dominique P Germain, et al.
Page
of 38